Table 1.
Baseline characteristics for the 23 patients
| Clinical variable | Value |
|---|---|
| Age (years) | 63 ± 9 |
| Sex (n) | |
| Male | 21 |
| Female | 2 |
| Child-Pugh class* (n) | |
| A5 | 19 |
| A6 | 2 |
| B7 | 1 |
| BCLC stage (n) | |
| B | 2 |
| C | 21 |
| Prior local therapy** (n) | |
| Yes | 6 |
| No | 17 |
| Tumor morphology (n) | |
| Infiltrative | 15 |
| Nodular | 8 |
| Portal vein thrombosis (n) | |
| Yes | 20 |
| No | 3 |
| Total tumor volume (mL)*** | |
| Mean ± SD | 437 ± 344 |
| Median [range] | 353 [58–1250] |
| Liver tumor involvement (n) | |
| < 25% | 15 |
| 25–50% | 8 |
| Treatment (n + 1) | |
| Whole liver | 1 |
| Lobar | 17 |
| Sectorial | 4 |
| Segmental | 2 |
WHO World Health Organization, BCLC Barcelona Clinic Liver Cancer
*One patient was non-cirrhotic
**Prior local therapies include chemoembolization and radiofrequency ablation
***Number of lesions was 1 for all treatments except one treatment that concerned 2 lesions